Bessemer Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7K Buy
+245
New +$7K ﹤0.01% 1917
2025
Q1
Sell
-70
Closed -$4K 2488
2024
Q4
$4K Sell
70
-165
-70% -$9.43K ﹤0.01% 2047
2024
Q3
$12K Buy
235
+43
+22% +$2.2K ﹤0.01% 1617
2024
Q2
$9K Buy
+192
New +$9K ﹤0.01% 1543